001367 海森药业
交易中 08-26 13:49:24
资讯
新帖
简况
海森药业（001367）披露独立董事候选人取得培训证明公告，8月25日股价上涨0.83%
证券之星 · 08-25 22:36
海森药业（001367）披露独立董事候选人取得培训证明公告，8月25日股价上涨0.83%
海森药业(001367)8月10日股东户数0.9万户，较上期减少10%
证券之星 · 08-21
海森药业(001367)8月10日股东户数0.9万户，较上期减少10%
异动快报：海森药业（001367）8月21日9点34分触及涨停板
证券之星 · 08-21
异动快报：海森药业（001367）8月21日9点34分触及涨停板
图解海森药业中报：第二季度单季净利润同比增长24.49%
证券之星 · 08-21
图解海森药业中报：第二季度单季净利润同比增长24.49%
海森药业(001367)8月10日股东户数0.9万户，较上期减少10%
证券之星 · 08-17
海森药业(001367)8月10日股东户数0.9万户，较上期减少10%
公司问答丨海森药业：目前公司生产经营情况正常 产能利用情况及在手订单情况良好
格隆汇 · 08-17
公司问答丨海森药业：目前公司生产经营情况正常 产能利用情况及在手订单情况良好
海森药业：公司现有厂区制剂产线已建成
证券之星 · 08-12
海森药业：公司现有厂区制剂产线已建成
股市必读：海森药业(001367)股东户数1万户，较上期增加11.11%
证券之星 · 07-27
股市必读：海森药业(001367)股东户数1万户，较上期增加11.11%
海森药业：截至2026年7月20日，公司股东总户数约为1万户
证券之星 · 07-24
海森药业：截至2026年7月20日，公司股东总户数约为1万户
海森药业：截至2026年7月10日股东总户数约为0.9万户
证券之星 · 07-14
海森药业：截至2026年7月10日股东总户数约为0.9万户
7月12日海森药业发布公告，股东减持12.01万股
证券之星 · 07-12
7月12日海森药业发布公告，股东减持12.01万股
异动快报：海森药业（001367）7月3日9点34分触及涨停板
证券之星 · 07-03
异动快报：海森药业（001367）7月3日9点34分触及涨停板
海森药业（001367）披露注销部分募集资金现金管理产品专用结算账户公告，6月25日股价下跌2.01%
证券之星 · 06-25
海森药业（001367）披露注销部分募集资金现金管理产品专用结算账户公告，6月25日股价下跌2.01%
海森药业（001367）披露完成法定代表人工商变更登记公告，6月2日股价下跌2.7%
证券之星 · 06-02
海森药业（001367）披露完成法定代表人工商变更登记公告，6月2日股价下跌2.7%
海森药业（001367）披露变更持续督导保荐代表人公告，5月28日股价下跌1.28%
证券之星 · 05-28
海森药业（001367）披露变更持续督导保荐代表人公告，5月28日股价下跌1.28%
海森药业：截至2026年5月8日，公司股东总户数约为1.1万户
证券之星 · 05-13
海森药业：截至2026年5月8日，公司股东总户数约为1.1万户
海森药业（001367）披露2025年年度权益分派实施公告，5月6日股价下跌0.17%
证券之星 · 05-06
海森药业（001367）披露2025年年度权益分派实施公告，5月6日股价下跌0.17%
每周股票复盘：海森药业（001367）股东户数增36.27%至1.36万户
证券之星 · 05-03
每周股票复盘：海森药业（001367）股东户数增36.27%至1.36万户
股市必读：海森药业一季报 - 第一季度单季净利润同比下降7.38%
证券之星 · 04-29
股市必读：海森药业一季报 - 第一季度单季净利润同比下降7.38%
图解海森药业一季报：第一季度单季净利润同比下降7.38%
证券之星 · 04-28
图解海森药业一季报：第一季度单季净利润同比下降7.38%
加载更多
公司概况
公司名称：
浙江海森药业股份有限公司
所属行业：
医药制造业
上市日期：
2023-04-10
主营业务：
浙江海森药业股份有限公司的主营业务是化学药品原料药及中间体研发、生产和销售。公司的主要产品是原料药。
发行价格：
44.48
{"stockData":{"symbol":"001367","market":"SZ","secType":"STK","nameCN":"海森药业","latestPrice":20.43,"timestamp":1787723364000,"preClose":20.61,"halted":0,"volume":4276407,"delay":0,"changeRate":-0.0087,"floatShares":122000000,"shares":152000000,"eps":0.9244,"marketStatus":"交易中","change":-0.18,"latestTime":"08-26 13:49:24","open":20.3,"high":21.26,"low":20.3,"amount":88504800,"amplitude":0.0466,"askPrice":20.44,"askSize":22,"bidPrice":20.43,"bidSize":159,"shortable":0,"etf":0,"ttmEps":0.9244,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1787727600000},"marketStatusCode":2,"adr":0,"adjPreClose":20.61,"symbolType":"stock","openAndCloseTimeList":[[1787707800000,1787715000000],[1787720400000,1787727600000]],"highLimit":22.67,"lowLimit":18.55,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":152351200,"isCdr":false,"pbRate":2.03,"roa":"--","peRate":22.100822,"roe":"4.31%","epsLYR":0.91,"committee":0.856934,"marketValue":3113000000,"turnoverRate":0.0352,"status":1,"floatMarketCap":2485000000},"requestUrl":"/m/hq/s/001367","defaultTab":"news","newsList":[{"id":"2662675360","title":"海森药业（001367）披露独立董事候选人取得培训证明公告，8月25日股价上涨0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662675360","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662675360?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:36","pubTimestamp":1787668594,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，海森药业报收于20.61元，较前一交易日上涨0.83%，最新总市值为31.4亿元。近日，浙江海森药业股份有限公司披露《关于独立董事候选人取得独立董事培训证明的公告》。公告显示，公司于2026年8月20日召开第三届董事会第二十一次会议，审议通过提名陈波先生为第四届董事会独立董事候选人。截至股东会通知发出日，陈波先生尚未取得深圳证券交易所认可的独立董事培训证明，但已承诺参加培训并取得证明。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500051296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661269280","title":"海森药业(001367)8月10日股东户数0.9万户，较上期减少10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661269280","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661269280?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:42","pubTimestamp":1787305346,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海森药业披露，截至2026年8月10日公司股东户数为9000.0户，较7月20日减少1000.0户，减幅为10.0%。在化学制药行业个股中，海森药业股东户数低于行业平均水平，截至8月10日，化学制药行业平均股东户数为3.68万户。从股价来看，2026年7月20日至2026年8月10日，海森药业区间涨幅为5.34%，在此期间股东户数减少1000.0户，减幅为10.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100032451.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661359256","title":"异动快报：海森药业（001367）8月21日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2661359256","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661359256?lang=zh_cn&edition=full","pubTime":"2026-08-21 09:36","pubTimestamp":1787276218,"startTime":"0","endTime":"0","summary":"证券之星8月21日盘中消息，9点34分海森药业（001367）触及涨停板。其所属行业化学制药目前上涨。领涨股为键凯科技。该股为医药，化学原料药概念热股。8月20日的资金流向数据方面，主力资金净流出8.67万元，占总成交额0.17%，游资资金净流出44.44万元，占总成交额0.88%，散户资金净流入53.12万元，占总成交额1.05%。近5日资金流向一览见下表：海森药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100010830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661451239","title":"图解海森药业中报：第二季度单季净利润同比增长24.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661451239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661451239?lang=zh_cn&edition=full","pubTime":"2026-08-21 01:49","pubTimestamp":1787248156,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业2026年中报显示，上半年度公司主营收入2.51亿元，同比上升3.64%；归母净利润6573.54万元，同比上升8.13%；扣非净利润6319.97万元，同比上升6.67%；其中2026年第二季度，公司单季度主营收入1.44亿元，同比上升16.25%；单季度归母净利润3682.69万元，同比上升24.49%；单季度扣非净利润3569.15万元，同比上升22.66%；负债率6.91%，投资收益205.02万元，财务费用106.0万元，毛利率46.58%。财报数据概要请见下图:本文数据来源于海森药业2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100001335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660486281","title":"海森药业(001367)8月10日股东户数0.9万户，较上期减少10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660486281","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660486281?lang=zh_cn&edition=full","pubTime":"2026-08-17 17:36","pubTimestamp":1786959373,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海森药业披露，截至2026年8月10日公司股东户数为9000.0户，较7月20日减少1000.0户，减幅为10.0%。在化学制药行业个股中，海森药业股东户数低于行业平均水平，截至8月10日，化学制药行业平均股东户数为3.62万户。从股价来看，2026年7月20日至2026年8月10日，海森药业区间涨幅为5.34%，在此期间股东户数减少1000.0户，减幅为10.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700023201.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660880234","title":"公司问答丨海森药业：目前公司生产经营情况正常 产能利用情况及在手订单情况良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2660880234","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660880234?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:15","pubTimestamp":1786954530,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658942690","title":"海森药业：公司现有厂区制剂产线已建成","url":"https://stock-news.laohu8.com/highlight/detail?id=2658942690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658942690?lang=zh_cn&edition=full","pubTime":"2026-08-12 08:51","pubTimestamp":1786495870,"startTime":"0","endTime":"0","summary":"建议依托自有原料药优势发展制剂业务，提升盈利水海森药业回复：感谢您的建议！目前，公司现有厂区制剂产线已建成，新区的规划建设包含制剂产线内容。当前公司正在推进投产筹备与相关建设工作，同时持续申报配套制剂品种。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200007361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654645080","title":"股市必读：海森药业(001367)股东户数1万户，较上期增加11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654645080","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654645080?lang=zh_cn&edition=full","pubTime":"2026-07-27 02:00","pubTimestamp":1785088844,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，海森药业报收于16.96元，下跌3.69%，换手率1.02%，成交量1.24万手，成交额2140.66万元。交易信息汇总资金流向7月24日主力资金净流出277.01万元，占总成交额0.0%；游资资金净流入301.46万元，占总成交额0.0%；散户资金净流出24.45万元，占总成交额0.0%。股本股东变化股东户数变动截至2026年7月20日公司股东户数为1.0万户，较7月10日增加1000.0户，增幅为11.11%。户均持股数量由上期的1.69万股减少至1.52万股，户均持股市值为27.65万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700000957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653098777","title":"海森药业：截至2026年7月20日，公司股东总户数约为1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653098777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653098777?lang=zh_cn&edition=full","pubTime":"2026-07-24 09:21","pubTimestamp":1784856072,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问7.20公司股东人数是多少？海森药业回复：尊敬的投资者，您好！根据中登公司最新下发的股东名册，截至2026年7月20日，公司股东总户数约为1万户。谢谢您的关注和支持！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400008410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651285251","title":"海森药业：截至2026年7月10日股东总户数约为0.9万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2651285251","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651285251?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:43","pubTimestamp":1783989786,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)07月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问6.30及7.10公司股东人数海森药业回复：尊敬的投资者，您好！根据中登公司最新下发的股东名册，截至2026年7月10日，公司股东总户数约为0.9万户。公司2026年6月30日的股东人数将于2026年半年度报告中披露，谢谢您的关注和支持本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400008436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650016819","title":"7月12日海森药业发布公告，股东减持12.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650016819","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650016819?lang=zh_cn&edition=full","pubTime":"2026-07-12 17:00","pubTimestamp":1783846855,"startTime":"0","endTime":"0","summary":"证券之星消息，7月12日海森药业发布公告《海森药业:关于持股5%以上股东提前终止减持计划暨减持结果的公告》，其股东东阳泰齐投资管理合伙企业(有限合伙)于2026年7月3日至2026年7月6日间合计减持12.01万股，占公司目前总股本的0.0788%，变动期间该股股价上涨2.9%，截止7月6日收盘报19.9元。股东增减持详情见下表：根据海森药业2026年一季报公布的十大股东详情如下：本文数据来源于海森药业公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200007835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648324886","title":"异动快报：海森药业（001367）7月3日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2648324886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648324886?lang=zh_cn&edition=full","pubTime":"2026-07-03 09:35","pubTimestamp":1783042543,"startTime":"0","endTime":"0","summary":"证券之星7月3日盘中消息，9点34分海森药业（001367）触及涨停板。其所属行业化学制药目前上涨。领涨股为向日葵。该股为医药，化学原料药概念热股，当日医药概念上涨1.5%，化学原料药概念上涨1.35%。7月2日的资金流向数据方面，主力资金净流入91.25万元，占总成交额2.42%，游资资金净流入14.38万元，占总成交额0.38%，散户资金净流出105.63万元，占总成交额2.8%。近5日资金流向一览见下表：海森药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070300010913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646801165","title":"海森药业（001367）披露注销部分募集资金现金管理产品专用结算账户公告，6月25日股价下跌2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646801165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646801165?lang=zh_cn&edition=full","pubTime":"2026-06-25 23:03","pubTimestamp":1782399802,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，海森药业报收于19.06元，较前一交易日下跌2.01%，最新总市值为29.04亿元。近日，浙江海森药业股份有限公司发布《关于注销部分募集资金现金管理产品专用结算账户的公告》。公告显示，因浙商证券股份有限公司东阳环城北路证券营业部的募集资金现金管理产品专用结算账户已不再使用且无后续使用计划，公司决定注销该账户，账户资金账号为537023832。其余相关账户仍正常使用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914968","title":"海森药业（001367）披露完成法定代表人工商变更登记公告，6月2日股价下跌2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640914968?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:15","pubTimestamp":1780395319,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，海森药业报收于20.17元，较前一交易日下跌2.7%，最新总市值为30.73亿元。近日，浙江海森药业股份有限公司发布公告称，公司于2026年4月27日召开第三届董事会第二十次会议，审议通过选举王雨潇为公司董事长及代表公司执行公司事务的董事，据此变更法定代表人。公司已完成相关工商变更登记手续，并取得浙江省市场监督管理局换发的营业执照，法定代表人由王式跃变更为王雨潇，其他营业执照内容不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200036496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638669449","title":"海森药业（001367）披露变更持续督导保荐代表人公告，5月28日股价下跌1.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638669449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638669449?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:58","pubTimestamp":1779980292,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，海森药业报收于20.85元，较前一交易日下跌1.28%，最新总市值为31.77亿元。近日，浙江海森药业股份有限公司发布公告，由于原持续督导保荐代表人徐峰先生因工作变动不再担任相关职务，中信证券委派郭阳先生接替其工作。变更后，持续督导保荐代表人为董超先生和郭阳先生，督导期至中国证监会和深交所规定的义务结束为止。本次变更不影响持续督导工作和公司正常经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635427580","title":"海森药业：截至2026年5月8日，公司股东总户数约为1.1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2635427580","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635427580?lang=zh_cn&edition=full","pubTime":"2026-05-13 11:34","pubTimestamp":1778643264,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问一下贵公司5月10日股东人数是多少？海森药业回复：尊敬的投资者，您好！根据中登公司最新下发的股东名册，截至2026年5月8日，公司股东总户数约为1.1万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300017756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633186792","title":"海森药业（001367）披露2025年年度权益分派实施公告，5月6日股价下跌0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633186792","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633186792?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:09","pubTimestamp":1778062175,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，海森药业报收于23.66元，较前一交易日下跌0.17%，最新总市值为36.05亿元。该股当日开盘23.7元，最高23.79元，最低23.14元，成交额达1.05亿元，换手率为3.67%。公司于近日披露《2025年年度权益分派实施公告》。公告显示，浙江海森药业股份有限公司2025年年度权益分派方案已获股东会审议通过，以公司总股本152,351,200股为基数，向全体股东每10股派1.16元现金（含税）。本次分配方案与股东会审议通过的一致，且实施时间未超过两个月。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600029249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632667720","title":"每周股票复盘：海森药业（001367）股东户数增36.27%至1.36万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2632667720","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2632667720?lang=zh_cn&edition=full","pubTime":"2026-05-03 06:08","pubTimestamp":1777759697,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，海森药业报收于23.7元，较上周的25.46元下跌6.91%。本周，海森药业4月27日盘中最高价报25.99元。海森药业当前最新总市值36.11亿元，在化学制药板块市值排名123/150，在两市A股市值排名4242/5200。本周关注点股本股东变化：股东户数增36.27%至1.36万户业绩披露要点：一季度主营收入1.07亿元，同比下降9.53%股本股东变化股东户数变动截至2026年3月31日，公司股东户数为1.36万户，较3月20日增加3627.0户，增幅36.27%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631530939","title":"股市必读：海森药业一季报 - 第一季度单季净利润同比下降7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631530939","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2631530939?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:26","pubTimestamp":1777418781,"startTime":"0","endTime":"0","summary":"来自业绩披露要点：2026年一季度海森药业主营收入同比下降9.53%，归母净利润同比下降7.38%。股本股东变化股东户数变动近日海森药业披露，截至2026年3月31日公司股东户数为1.36万户，较3月20日增加3627.0户，增幅为36.27%。业绩披露要点财务报告海森药业2026年一季报显示，一季度公司主营收入1.07亿元，同比下降9.53%；归母净利润2890.84万元，同比下降7.38%；扣非净利润2750.82万元，同比下降8.77%；负债率6.54%，投资收益127.35万元，财务费用52.53万元，毛利率48.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900021700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630106293","title":"图解海森药业一季报：第一季度单季净利润同比下降7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630106293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630106293?lang=zh_cn&edition=full","pubTime":"2026-04-28 04:35","pubTimestamp":1777322113,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业2026年一季报显示，一季度公司主营收入1.07亿元，同比下降9.53%；归母净利润2890.84万元，同比下降7.38%；扣非净利润2750.82万元，同比下降8.77%；负债率6.54%，投资收益127.35万元，财务费用52.53万元，毛利率48.19%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800012422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787723367356,"stockEarnings":[{"period":"1week","weight":0.042},{"period":"1month","weight":0.2152},{"period":"3month","weight":-0.0241},{"period":"6month","weight":-0.1311},{"period":"1year","weight":-0.2201},{"period":"ytd","weight":-0.0566}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.0197},{"period":"3month","weight":-0.0499},{"period":"6month","weight":-0.062},{"period":"1year","weight":0.0015},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江海森药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9000人(较上一季度减少10.00%)","perCapita":"13512股","listingDate":"2023-04-10","address":"浙江省金华市东阳市六石街道香潭村","registeredCapital":"15235万元","survey":" 浙江海森药业股份有限公司的主营业务是化学药品原料药及中间体研发、生产和销售。公司的主要产品是原料药。","listedPrice":44.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海森药业(001367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海森药业(001367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海森药业,001367,海森药业股票,海森药业股票老虎,海森药业股票老虎国际,海森药业行情,海森药业股票行情,海森药业股价,海森药业股市,海森药业股票价格,海森药业股票交易,海森药业股票购买,海森药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海森药业(001367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海森药业(001367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}